|
ARID1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.35860000000299E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.028610E-04 |
| Normal-vs-Stage2 |
3.148400E-02 |
| Normal-vs-Stage3 |
3.13849999988847E-07 |
| Normal-vs-Stage4 |
6.33009999972955E-07 |
| Stage1-vs-Stage2 |
3.039600E-01 |
| Stage1-vs-Stage3 |
1.055150E-01 |
| Stage1-vs-Stage4 |
5.230200E-02 |
| Stage2-vs-Stage3 |
3.579600E-02 |
| Stage2-vs-Stage4 |
3.073500E-02 |
| Stage3-vs-Stage4 |
6.560600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75437999999639E-05 |
| Normal-vs-AfricanAmerican |
3.141900E-02 |
| Normal-vs-Asian |
3.7045999999985E-05 |
| Caucasian-vs-AfricanAmerican |
3.966000E-01 |
| Caucasian-vs-Asian |
4.940200E-01 |
| AfricanAmerican-vs-Asian |
1.933400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.2172000000027E-05 |
| Normal-vs-Female |
4.75570000002534E-06 |
| Male-vs-Female |
9.547800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.90589999999569E-05 |
| Normal-vs-Age(41-60Yrs) |
8.43480000000119E-05 |
| Normal-vs-Age(61-80Yrs) |
3.65160000004305E-06 |
| Normal-vs-Age(81-100Yrs) |
5.000800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.356600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.883600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.762400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.925800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.758200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.777000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.415100E-04 |
| Classical-VS-Follicular |
6.632000E-01 |
| Classical-VS-Other |
2.271800E-01 |
| Classical-VS-Normal |
8.44070000000086E-05 |
| Tall-VS-Follicular |
1.613800E-02 |
| Tall-VS-Other |
8.424600E-01 |
| Tall-VS-Normal |
1.63440000422455E-08 |
| Follicular-VS-Other |
4.101800E-01 |
| Follicular-VS-Normal |
6.572600E-04 |
| Other-VS-Normal |
6.980100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.164350E-04 |
| Normal-vs-N1 |
4.22210000294854E-08 |
| N0-vs-N1 |
2.000400E-02 |
|
|
